These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 30013382)
1. Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitis. Graf C; Bernkop-Schnürch A; Egyed A; Koller C; Prieschl-Grassauer E; Morokutti-Kurz M Int J Gen Med; 2018; 11():275-283. PubMed ID: 30013382 [TBL] [Abstract][Full Text] [Related]
2. Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold. Fazekas T; Eickhoff P; Pruckner N; Vollnhofer G; Fischmeister G; Diakos C; Rauch M; Verdianz M; Zoubek A; Gadner H; Lion T BMC Complement Altern Med; 2012 Sep; 12():147. PubMed ID: 22950667 [TBL] [Abstract][Full Text] [Related]
4. A real-world study of quality of life following treatment with xylometazoline hydrochloride in individuals with common cold. Hagen M; Clark K; Kalita P; Serra G; Sanchez E; Varbiro G; Albasser MM Ther Adv Respir Dis; 2024; 18():17534666241228927. PubMed ID: 38372128 [TBL] [Abstract][Full Text] [Related]
5. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold. Eccles R; Martensson K; Chen SC Curr Med Res Opin; 2010 Apr; 26(4):889-99. PubMed ID: 20151787 [TBL] [Abstract][Full Text] [Related]
6. Iota-Carrageenan is a potent inhibitor of rhinovirus infection. Grassauer A; Weinmuellner R; Meier C; Pretsch A; Prieschl-Grassauer E; Unger H Virol J; 2008 Sep; 5():107. PubMed ID: 18817582 [TBL] [Abstract][Full Text] [Related]
7. The Saliva of Probands Sucking an Iota-Carrageenan Containing Lozenge Inhibits Viral Binding and Replication of the Most Predominant Common Cold Viruses and SARS-CoV-2. Morokutti-Kurz M; Unger-Manhart N; Graf P; Rauch P; Kodnar J; Große M; Setz C; Savli M; Ehrenreich F; Grassauer A; Prieschl-Grassauer E; Schubert U Int J Gen Med; 2021; 14():5241-5249. PubMed ID: 34526804 [TBL] [Abstract][Full Text] [Related]
8. Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat. Morokutti-Kurz M; Graf C; Prieschl-Grassauer E Int J Gen Med; 2017; 10():53-60. PubMed ID: 28280379 [TBL] [Abstract][Full Text] [Related]
9. Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study. Castellano F; Mautone G Drugs Exp Clin Res; 2002; 28(1):27-35. PubMed ID: 12073765 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold. Eccles R; Meier C; Jawad M; Weinmüllner R; Grassauer A; Prieschl-Grassauer E Respir Res; 2010 Aug; 11(1):108. PubMed ID: 20696083 [TBL] [Abstract][Full Text] [Related]
11. Topical glucocorticoid reduces the topical decongestant-induced histologic changes in an animal model nasal mucosa. Akpinar ME; Yigit O; Akakin D; Sarioz O; Ozkan N; Yildiz SD; Azizli E; Sehirli US Laryngoscope; 2012 Apr; 122(4):741-6. PubMed ID: 22374848 [TBL] [Abstract][Full Text] [Related]
12. Novel nasal formulation of xylometazoline with hyaluronic acid: In vitro ciliary beat frequency study. Tratnjek L; Simić L; Vukelić K; Knežević Z; Kreft ME Eur J Pharm Biopharm; 2023 Nov; 192():136-146. PubMed ID: 37804998 [TBL] [Abstract][Full Text] [Related]
13. The nasal decongestant effect of xylometazoline in the common cold. Eccles R; Eriksson M; Garreffa S; Chen SC Am J Rhinol; 2008; 22(5):491-6. PubMed ID: 18655753 [TBL] [Abstract][Full Text] [Related]
14. Immediate effect of benzalkonium chloride in decongestant nasal spray on the human nasal mucosal temperature. Lindemann J; Leiacker R; Wiesmiller K; Rettinger G; Keck T Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):357-61. PubMed ID: 15270822 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection. Eccles R; Pedersen A; Regberg D; Tulento H; Borum P; Stjärne P Am J Rhinol; 2007; 21(1):40-5. PubMed ID: 17283559 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of iota-carrageenan nasal spray in treatment and prevention of the common cold. Bichiri D; Rente AR; Jesus  Med Pharm Rep; 2021 Jan; 94(1):28-34. PubMed ID: 33629045 [TBL] [Abstract][Full Text] [Related]
17. The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review. Frediansyah A Clin Epidemiol Glob Health; 2021; 12():100826. PubMed ID: 34222718 [TBL] [Abstract][Full Text] [Related]